Fatty acid amides as potential circulating biomarkers for sarcopenia.

Ye An KimSeung Hun LeeJung-Min KohSeung-Hyun KwonYoung LeeHan Jin ChoHanjun KimSu Jung KimJi Hyun LeeHyun Ju YooJe-Hyun Seo

Published in: Journal of cachexia, sarcopenia and muscle (2023)

Our study demonstrated that fatty acid amides are potential circulating biomarkers in elderly men with sarcopenia. DHA EA, in particular, strongly related to muscle mass and strength, can be a key metabolite to become a reliable metabolic biomarker for sarcopenia. Further research on fatty acid amides will provide insights into the metabolomic changes relevant to sarcopenia from an aging perspective.

Keyphrases

fatty acid
community dwelling
skeletal muscle
middle aged
human health
risk assessment
drug induced